FORGOT YOUR DETAILS?

LINK Pharmaceuticals: second major acquisition in 2008

by / Thursday, 25 September 2008 / Published in News

LINK Pharmaceuticals today announced a second major acquisition for 2008 with the transfer of the former Novartis products Apresoline, Deseril and Hygroton.

This transfer is an extension of LINK’s on-going partnership with the UK company Amdipharm.

Amdipharm recently completed the acquisition of these products from Novartis for several international markets and LINK will market them in Australia on Amdipharm’s behalf

TOP